Comparison of Nasal CPAP and Nasal SIMV in Transient Tachypnea of Newborn
NCT ID: NCT01499238
Last Updated: 2011-12-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
PHASE4
40 participants
INTERVENTIONAL
2011-12-31
2012-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
nasal SIMV
rate: 30-50/min, PIP: 16, PEEP: 4-6, fİO2: 40%
Nasal SIMV
rate: 30-50/min, PIP: 16-20, PEEP: 4-6, FİO2: 40%
nasal CPAP
PEEP: 4-6 mmHg, Fio2: 40%
nasal CPAP
PEEP: 4-6 mmHg, FİO2: 40%
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Nasal SIMV
rate: 30-50/min, PIP: 16-20, PEEP: 4-6, FİO2: 40%
nasal CPAP
PEEP: 4-6 mmHg, FİO2: 40%
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* wetlung
Exclusion Criteria
2 Hours
3 Days
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Zekai Tahir Burak Women's Health Research and Education Hospital
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Gamze Demirel
Zekai Tahir Burak Maternity Teaching Hospital
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Gamze Demirel, MD
Role: PRINCIPAL_INVESTIGATOR
Zekai Tahir Burak Women's Health Research and Education Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zekai Tahir Burak Maternity Teaching Hospital
Ankara, Ankara, Turkey (Türkiye)
Zekai Tahir Burak Maternity Teaching Hospital, Division of Neonatology
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Gamze Demirel, MD
Role: primary
Gamze Demirel, MD
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
4
Identifier Type: -
Identifier Source: org_study_id